IJCRRI Journ Cur Res ReInternational Journal of Current Research and ReviewI Journ Cur Res Re2231-21960975-5241Radiance Research Academy183HealthcareORAL LICHEN PLANUS: AN UPDATE IqubalMd. AsadKhanMobeenChaudharyUmesh ChandraSwetarchiFarhatBushraAkhtarNazish)3033This article is copyright of Popeye Publishing, 20092009This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.

Lichen planus is a mucocutaneous disease affecting approximately 1.5 to 2% of the world population. Oral lichen planus (OLP) is a chronic mucosal condition. It has various oral manifestations, the reticular form being the most common. The course of the disease is usually unpredictable with bouts of remission and exacerbation being common. The most widely accepted treatment for lesions of OLP involves topical or systemic corticosteroids to modulate the patient__ampersandsignrsquo;s immune response.

Lichen planus Mucocutaneous disease Oral lichen planus Lichenoid reaction Corticosteroids